Niagen Bioscience, Inc. (NAGE) stock
NAGENasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3013% below fair value
$2.01−0.06 (-2.66%)
Close on Nov 16, 2026Market cap $159.04MP/E 16.8Yield –
Niagen Bioscience gross margin
Gross margin is gross profit as a percentage of revenue.
Niagen Bioscience's gross margin for the twelve months ending Sep 30, 2026 was 63.9%. For fiscal 2025 it was 64.3%, against 61.8% the year before. The highest annual figure on record is 64.3% in fiscal 2025.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 64.3% | +2.4 |
| FY2024 | Dec 31, 2024 | 61.8% | +1.1 |
| FY2023 | Dec 31, 2023 | 60.8% | +1.4 |
| FY2022 | Dec 31, 2022 | 59.4% | −2.1 |
| FY2021 | Dec 31, 2021 | 61.5% | +2.0 |
| FY2020 | Dec 31, 2020 | 59.5% | +3.9 |
| FY2019 | Dec 31, 2019 | 55.7% | +4.8 |
| FY2018 | Dec 31, 2018 | 50.9% | +1.5 |
| FY2017 | Dec 30, 2017 | 49.4% | +1.5 |
| FY2016 | Dec 31, 2016 | 48.0% | +5.8 |
| FY2015 | Jan 2, 2016 | 42.1% | +7.4 |
| FY2014 | Jan 3, 2015 | 34.8% | +3.9 |
| FY2013 | Dec 28, 2013 | 30.8% | +11.2 |
| FY2012 | Dec 29, 2012 | 19.6% | −10.9 |
| FY2011 | Dec 31, 2011 | 30.5% | −8.5 |
| FY2010 | Jan 1, 2011 | 38.9% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 62.9% | −1.6 |
| Q2 FY2026 | Jun 30, 2026 | 64.8% | −0.2 |
| Q1 FY2026 | Mar 31, 2026 | 63.5% | +0.0 |
| Q4 FY2025 | Dec 31, 2025 | 64.1% | +1.7 |
| Q3 FY2025 | Sep 30, 2025 | 64.5% | +1.0 |
| Q2 FY2025 | Jun 30, 2025 | 65.0% | +4.8 |
| Q1 FY2025 | Mar 31, 2025 | 63.4% | +2.7 |
| Q4 FY2024 | Dec 31, 2024 | 62.5% | +1.4 |
| Q3 FY2024 | Sep 30, 2024 | 63.5% | +2.1 |
| Q2 FY2024 | Jun 30, 2024 | 60.2% | −0.6 |
| Q1 FY2024 | Mar 31, 2024 | 60.7% | +0.8 |
| Q4 FY2023 | Dec 31, 2023 | 61.0% | +3.8 |
| Q3 FY2023 | Sep 30, 2023 | 61.4% | +1.6 |
| Q2 FY2023 | Jun 30, 2023 | 60.8% | +0.8 |
| Q1 FY2023 | Mar 31, 2023 | 59.9% | −1.1 |
| Q4 FY2022 | Dec 31, 2022 | 57.2% | −4.0 |
| Q3 FY2022 | Sep 30, 2022 | 59.8% | −1.3 |
| Q2 FY2022 | Jun 30, 2022 | 60.0% | −1.1 |
| Q1 FY2022 | Mar 31, 2022 | 61.0% | −1.9 |
| Q4 FY2021 | Dec 31, 2021 | 61.2% | +0.2 |
| Q3 FY2021 | Sep 30, 2021 | 61.1% | +1.5 |
| Q2 FY2021 | Jun 30, 2021 | 61.1% | +1.6 |
| Q1 FY2021 | Mar 31, 2021 | 62.9% | +5.0 |
| Q4 FY2020 | Dec 31, 2020 | 61.0% | +4.0 |
| Q3 FY2020 | Sep 30, 2020 | 59.6% | +3.6 |
| Q2 FY2020 | Jun 30, 2020 | 59.4% | +3.1 |
| Q1 FY2020 | Mar 31, 2020 | 57.9% | +5.2 |
| Q4 FY2019 | Dec 31, 2019 | 57.0% | +5.1 |
| Q3 FY2019 | Sep 30, 2019 | 56.0% | +2.3 |
| Q2 FY2019 | Jun 30, 2019 | 56.3% | +7.0 |
| Q1 FY2019 | Mar 31, 2019 | 52.8% | +5.0 |
| Q4 FY2018 | Dec 31, 2018 | 52.0% | +1.0 |
| Q3 FY2018 | Sep 30, 2018 | 53.7% | +5.8 |
| Q2 FY2018 | Jun 30, 2018 | 49.3% | +4.1 |
| Q1 FY2018 | Mar 31, 2018 | 47.8% | +0.5 |
| Q4 FY2017 | Dec 30, 2017 | 50.9% | – |
| Q3 FY2017 | Sep 30, 2017 | 47.9% | – |
| Q4 FY2016 | Dec 31, 2016 | 45.1% | – |
| Q3 FY2016 | Oct 1, 2016 | 47.3% | – |
See a number that looks wrong?